Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes.

BACKGROUND Although several important studies have been performed in hypertensive type 2 diabetic patients, it is not known whether lowering blood pressure in normotensive (BP <140/90 mm Hg) patients offers any beneficial results on vascular complications. The current study evaluated the effect of intensive versus moderate diastolic blood pressure (DBP) control on diabetic vascular complications in 480 normotensive type 2 diabetic patients. METHODS The current study was a prospective, randomized controlled trial in normotensive type 2 diabetic subjects. The subjects were randomized to intensive (10 mm Hg below the baseline DBP) versus moderate (80 to 89 mm Hg) DBP control. Patients in the moderate therapy group were given placebo, while the patients randomized to intensive therapy received either nisoldipine or enalapril in a blinded manner as the initial antihypertensive medication. The primary end point evaluated was the change in creatinine clearance with the secondary endpoints consisting of change in urinary albumin excretion, progression of retinopathy and neuropathy and the incidence of cardiovascular disease. RESULTS The mean follow-up was 5.3 years. Mean BP in the intensive group was 128 +/- 0.8/75 +/- 0.3 mm Hg versus 137 +/- 0.7/81 +/- 0.3 mm Hg in the moderate group, P < 0.0001. Although no difference was demonstrated in creatinine clearance (P = 0.43), a lower percentage of patients in the intensive group progressed from normoalbuminuria to microalbuminuria (P = 0.012) and microalbuminuria to overt albuminuria (P = 0.028). The intensive BP control group also demonstrated less progression of diabetic retinopathy (P = 0.019) and a lower incidence of strokes (P = 0.03). The results were the same whether enalapril or nisoldipine was used as the initial antihypertensive agent. CONCLUSION Over a five-year follow-up period, intensive (approximately 128/75 mm Hg) BP control in normotensive type 2 diabetic patients: (1) slowed the progression to incipient and overt diabetic nephropathy; (2) decreased the progression of diabetic retinopathy; and (3) diminished the incidence of stroke.

[1]  M. Hanefeld,et al.  Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant α-lipoic acid , 1995, Diabetologia.

[2]  V. Pavlik,et al.  Characteristics of patients with uncontrolled hypertension in the United States. , 2001, The New England journal of medicine.

[3]  S. Yusuf,et al.  Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. , 2001, JAMA.

[4]  R. Schrier,et al.  Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes. , 2000, Diabetes care.

[5]  Bruce H. R. Wolffenbuttel,et al.  Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy , 2000, The Lancet.

[6]  S. Yusuf,et al.  Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators. , 2000 .

[7]  C. Bulpitt,et al.  Effects of Calcium-Channel Blockade in Older Patients with Diabetes and Systolic Hypertension , 1999 .

[8]  Philip D. Harvey,et al.  Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 , 1998, BMJ.

[9]  R. Holman,et al.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .

[10]  M. Ravid,et al.  Use of Enalapril To Attenuate Decline in Renal Function in Normotensive, Normoalbuminuric Patients with Type 2 Diabetes Mellitus , 1998, Annals of Internal Medicine.

[11]  Joël Ménard,et al.  Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial , 1998, The Lancet.

[12]  R. Schrier,et al.  Overt albuminuria predicts diabetic retinopathy in Hispanics with NIDDM. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[13]  Jeffrey A. Cohen,et al.  Risks for sensorimotor peripheral neuropathy and autonomic neuropathy in non‐insulin‐dependent diabetes mellitus (NIDDM) , 1998, Muscle & nerve.

[14]  R. Schrier,et al.  Angiotensin-converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus and its relationship with diabetic nephropathy. , 1997, Kidney international.

[15]  H. Parving,et al.  Differences Between Nisoldipine and Lisinopril on Glomerular Filtration Rates and Albuminuria in Hypertensive IDDM Patients With Diabetic Nephropathy During the First Year of Treatment , 1997, Diabetes.

[16]  R. Schrier,et al.  Increased complications in noninsulin-dependent diabetic patients treated with insulin versus oral hypoglycemic agents: a population study. , 1997, Proceedings of the Association of American Physicians.

[17]  S. Nielsen,et al.  The clinical course of renal function in NIDDM patients with normo‐ and microalbuminuria , 1997, Journal of internal medicine.

[18]  P. Mehler,et al.  Associations of hypertension and complications in non-insulin-dependent diabetes mellitus. , 1997, American journal of hypertension.

[19]  B. Davis,et al.  Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group. , 1996, JAMA.

[20]  A. Liberati,et al.  A Meta‐analysis of Trials on Aldose Reductase Inhibitors in Diabetic Peripheral Neuropathy , 1996, Diabetic medicine : a journal of the British Diabetic Association.

[21]  R. Schrier,et al.  Urinary Albumin Excretion as a Predictor of Diabetic Retinopathy, Neuropathy, and Cardiovascular Disease in NIDDM , 1996, Diabetes Care.

[22]  J. Regensteiner,et al.  Effect of Risk Factors on Exercise Capacity in NIDDM , 1996, Diabetes.

[23]  R. Schrier,et al.  Baseline characteristics of participants in the Appropriate Blood Pressure Control in Diabetes trial. , 1996, Controlled clinical trials.

[24]  P Whelton,et al.  Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991. , 1995, Hypertension.

[25]  R. Schrier,et al.  Clinical factors associated with urinary albumin excretion in type II diabetes. , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[26]  R. Klein,et al.  A cohort study of the relationship of diabetic retinopathy to blood pressure. , 1995, Archives of ophthalmology.

[27]  L. Hansson.  Effects of angiotensin-converting enzyme inhibition versus conventional antihypertensive therapy on the glomerular filtration rate. , 1995, Cardiology.

[28]  R. Klein,et al.  Ocular factors in the incidence and progression of diabetic retinopathy. , 1994, Ophthalmology.

[29]  M. Lishner,et al.  Long-Term Stabilizing Effect of Angiotensin-Converting Enzyme Inhibition on Plasma Creatinine and on Proteinuria in Normotensive Type II Diabetic Patients , 1993, Annals of Internal Medicine.

[30]  T. Merimee,et al.  Diabetic retinopathy. A synthesis of perspectives. , 1990, The New England journal of medicine.

[31]  R. Kahn.  Report and Recommendations of the San Antonio Conference on Diabetic Neuropathy , 1988, Diabetes Care.

[32]  P. Dyck.  Detection, characterization, and staging of polyneuropathy: Assessed in diabetics , 1988, Muscle & nerve.

[33]  H. Parving,et al.  Effect of antihypertensive treatment on kidney function in diabetic nephropathy. , 1987, British medical journal.

[34]  T. Aizawa,et al.  High Blood Pressure as Risk Factor in Diabetic Retinopathy Development in NIDDM Patients , 1987, Diabetes Care.

[35]  I. Constable,et al.  Prevalence of Diabetic Complications in Relation to Risk Factors , 1986, Diabetes.

[36]  E. Kohner,et al.  Blood Pressure and the Progression of Mild Background Diabetic Retinopathy , 1985, Hypertension.

[37]  M. Meyer,et al.  Role of risk factors in complications of diabetes mellitus. , 1980, American journal of epidemiology.

[38]  P. Bennett,et al.  Increased incidence of retinopathy in diabetics with elevated blood pressure. A six-year follow-up study in Pima Indians. , 1980, The New England journal of medicine.